FDA 483 - SOHM Inc. - November 05, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
SOHM, Inc. in Carlsbad, CA, was inspected regarding its manufacturing of OTC drug products, Salicylic Acid 2% and Hydroquinone USP 4%. The inspection revealed significant deficiencies across its quality system, including inadequate production and process controls, a non-existent quality control unit, and poor equipment and labeling management. These issues indicate a severe lack of adherence to cGMP regulations, potentially impacting drug product quality, safety, and purity.
ID · 3408d4e8-864b-4aea-ba87-707f06093fef